Article
Development of Therapies for Rare Genetic Disorders of GPX4: Roadmap and Opportunities
2021-04-05
Abstract excerpt
<h4>Background: </h4> Extremely rare progressive diseases like Sedaghatian-type Spondylometaphyseal Dysplasia (SSMD) can be neonatally lethal and therefore go undiagnosed or are difficult to treat. Recent sequencing efforts have linked this disease to mutations in GPX4, with consequences in the resulting enzyme, glutathione peroxidase 4. This offers potential diagnostic and therapeutic avenues for those suffering...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3a67cd64-2b53-5d45-9366-0debdab14ce3
- DOI
- 10.20944/preprints202104.0105.v1
